• GANT61: GLI Inhibitor Workflows for Tumor Immunotherapy Rese

  2026-08-01

  GANT61 empowers researchers to directly target GLI-driven tumor immune evasion and therapy resistance, unlocking new translational strategies. Explore optimized protocols, troubleshooting guidance, and advanced applications that set this GLI inhibitor apart for cancer research.

• DAPI (hydrochloride): Precision DNA Visualization & Workflow

  2026-07-31

  DAPI (hydrochloride) stands out as a gold-standard chromosome staining reagent, enabling precise DNA visualization in histochemistry, reliable cell cycle analysis, and advanced immuno-oncology workflows. This article bridges proven experimental setups with next-level troubleshooting, highlighting how APExBIO’s high-purity formulation empowers reproducible, high-sensitivity results even in challenging biological contexts.

• Tetracycline: Broad-Spectrum Polyketide Antibiotic Workflows

  2026-07-31

  Tetracycline enables precision in antibiotic selection and advanced ribosomal research, thanks to its well-characterized mechanism and robust solubility. This guide distills experimental best practices, troubleshooting insights, and novel applications, ensuring researchers extract maximum value from APExBIO’s high-purity Tetracycline.

• Differential Analysis of Chuanxiong Cortex and Pith in CHD T

  2026-07-30

  This study applies advanced SPME-GC×GC-MS and network pharmacology to reveal unique bioactive profiles and mechanisms of the cortex and pith of Ligusticum chuanxiong in coronary heart disease (CHD) prevention. The findings provide detailed molecular insight into tissue-specific targets and pathways, guiding more precise use of herbal extracts for CHD interventions.

• GKT137831: Redefining Dual Nox1/Nox4 Inhibition in Ferroptos

  2026-07-30

  Discover how GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor, uniquely advances oxidative stress, ferroptosis, and vascular remodeling research by integrating the latest mechanistic insights. This cornerstone article explores distinct translational strategies and practical protocols.

• Escitalopram in Advanced Antidepressant Research: Selectivit

  2026-07-29

  Explore how Escitalopram, a highly selective SSRI, advances antidepressant and anxiolytic research through molecular selectivity and assay optimization. This article uniquely dissects experimental design choices and practical insights for neuroscience investigations.

• Molidustat (BAY85-3934): Shaping Next-Gen Renal Anemia Resea

  2026-07-29

  Explore how Molidustat (BAY85-3934) leverages hypoxia-inducible factor stabilization to advance renal anemia research, providing strategic insight for translational teams. This article integrates mechanistic findings, experimental recommendations, and clinical perspectives—bridging foundational biochemistry with forward-looking, actionable strategies, and highlighting APExBIO's leadership in HIF-PH inhibitor innovation.

• Sodium Oxamate: Mechanism and Benchmarks in Cancer Metabolis

  2026-07-28

  Sodium Oxamate is a validated competitive inhibitor of LDH-A and a key tool in cancer metabolism research. Its ability to reduce lactate production disrupts critical survival pathways in rapidly proliferating tumor cells. This article details its mechanistic basis, peer-reviewed evidence, and protocol integration for metabolic reprogramming studies.

• Fosinopril Sodium: Optimizing ACE Inhibitor Workflows in Hyp

  2026-07-28

  Fosinopril sodium delivers high-precision ACE inhibition, uniquely supporting cardiovascular and renal models with its dual elimination profile. This guide details practical workflows, advanced troubleshooting, and translational protocol enhancements to maximize reproducibility and research impact.

• ALDH2 Activation Extends Cardiomyocyte Proliferation in Hear

  2026-07-27

  This study reveals that ALDH2 activation, including via Alda 1, significantly promotes cardiomyocyte proliferation in mice, delaying pressure overload-induced heart failure. The findings highlight a previously underappreciated role for ALDH2 in cardiac regeneration, suggesting new therapeutic directions for cardiac ischemia research.

• OSMI-1: Precision O-GlcNAc Transferase Inhibition in Preecla

  2026-07-27

  OSMI-1 enables robust, quantitative modulation of protein O-GlcNAcylation, unlocking targeted studies of ferroptosis and syncytialization in placental biology. Its high purity, cell permeability, and defined activity profile make it the benchmark inhibitor for dissecting O-GlcNAc-dependent pathways in both cellular and in vivo models.

• ATM-Targeted TACE Silencing for Obesity-Induced Diabetes The

  2026-07-26

  The reference study introduces a targeted gene delivery strategy using ATS-9R to silence TACE expression in visceral adipose tissue macrophages (ATMs), leading to reduced inflammation and improved insulin sensitivity in obese mice. This work highlights the potential of prohibitin-mediated non-viral gene silencing as a therapeutic approach for obesity-induced type 2 diabetes.

• p53/PUMA-Mediated Synthetic Lethality via WRN Loss in MSI CR

  2026-07-25

  The reference study uncovers how Werner (WRN) helicase depletion or inhibition triggers p53/PUMA-dependent apoptosis specifically in mismatch repair-deficient (MSI) colorectal cancer cells. These findings mechanistically clarify synthetic lethality in this context and highlight WRN as a promising therapeutic target for p53-wildtype MSI CRCs.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Insig

  2026-07-24

  The referenced study identifies moesin (MSN) as a novel biomarker for endothelial injury in sepsis, linking its serum levels to severity and outcomes. Rigorous in vivo and in vitro experiments clarify MSN's mechanistic role in endothelial dysfunction, offering new directions for both diagnostics and targeted research.

• Annexin V-PE Reagent (SKU K2280): Reliable Apoptosis Detecti

  2026-07-24

  This authoritative review examines how Annexin V-PE Reagent (SKU K2280) addresses core challenges in apoptosis and cell death assays, providing reproducible, sensitive phosphatidylserine externalization detection. By integrating real-world lab scenarios, protocol parameters, and evidence-based vendor comparisons, the article equips researchers and lab technicians with reliable strategies to streamline cell viability workflows using Annexin V-PE Reagent.

401 records 6/27 page Previous Next First page 上5页 678910 下5页 Last page